Hints and tips:
Showing results for Takeda Pharmaceuticals North America, Inc
Related Special Reports
...Pfizer: The pharmaceutical company is expected to report that quarterly revenue declined 23.4 per cent from the same period last year to $14bn, according to LSEG, as the company faces weak demand for its...
...So effective is Vertex Pharmaceuticals’ blockbuster cystic fibrosis (CF) drug, Trikafta, that studies project it could extend the lives of some young patients by up to 45 years....
...This month Brazil started distributing a vaccine produced by Japanese pharmaceutical group Takeda....
...It is struggling to raise enough funding for clinical trials, because metformin is a generic drug, so offers insufficient profit to pharmaceutical companies....
...California has taken a first step to push down pharmaceutical prices in the US state, striking a deal with the maker of a drug that can reverse opioid overdoses to purchase the medicine at a large discount...
...Moderna: The pharmaceutical group will hold its annual investor day, when shareholders will be keen to learn more about how it plans to grow its business beyond the Covid-19 pandemic....
...Still, Delaware, Inc is going to have to decide whether its brand should be based on being an even-handed, dispassionate system or something more corporate-friendly, designed to keep up in a regulatory race...
...The pharmaceutical company’s market capitalisation recently overtook Tesla thanks to investor enthusiasm over Mounjaro’s success. Earnings are expected to decrease by three cents to $2.11 a share....
...America....
...Pharma: Pharmaceutical groups Bristol Myers Squibb, Regeneron and AbbVie will also report earnings before the market opens....
...Friday’s decision comes after the state of New Hampshire failed in its bid to receive FDA permission because it did not identify a pharmaceutical wholesaler which could deliver the drugs....
...The US market is the engine of the global pharmaceutical industry. Its exceptionally high drug prices help deliver as much as three-quarters of the sector’s global profits....
Also in today’s newsletter, a new twist in the Science-Based Targets initiative drama
...Gilead Sciences fell 10.5 per cent after the pharmaceutical company said its treatment for lung cancer failed to improve the survival of patients in its latest trial....
But the boost to liquidity can prove shortlived
...It was unbelievable,” said Alisha Alaimo, Biogen’s North America head....
Drug developers raised $6bn in January, helped by a rebound in merger activity
...In contrast, pharmaceutical companies raised just $160mn for antibiotic research, a decline over the decade. Commercial activity and research in antibiotics have been in decline since the 1980s....
Tesla wants to relocate its corporate domicile but institutional investors like Delaware’s sophistication and predictability
...“There was a huge outflow from ESGU and into QUAL as a result of BlackRock changing their weighting,” said Bryan Armour, director of passive strategies research for North America at Morningstar....
Tesla boss shows Argentine president Texas factory where they talked about lithium, Brazil and a disdain for bureaucracy
...By the mid-1800s, the US bracketed the landmass called North America....
And more on bad buybacks
...Large drugmakers have also underperformed, with the S&P 500 pharmaceutical sub-index heading for its worst performance relative to the broader S&P 500 in at least 20 years....
Delaware court previously voided chief executive’s $56bn remuneration
International Edition